Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for NASDAQ stock ALNY Alnylam Pharmaceuticals. Dated: 19 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 229.48 and Closed at: 242.66, which is 5.79% of previous session's close. It moved within a range of 229.48 and 244.03
The session was a Bullish session with an average volume of 1172282, which is -36.51% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 236.07 and resistance for tomorrow is 250.62
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 233.42, 224.17 resistance for tomorrow's hourly charts is 247.97, 253.27
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 224.91 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 236.26 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 268.59 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 287.22 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 331.57 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 236.26 and 200 DMA is at 331.57, while 50 DMA and 100 DMA are at 268.59 and 287.22 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 236.26 and 20 EMA is at 237.99
| Date | Closing Price | 20 SMA | 20 EMA |
| 19 Wed Aug | 242.66 | 236.26 | 237.99 |
| 18 Tue Aug | 228.61 | 237.56 | 237.5 |
| 17 Mon Aug | 224.60 | 239.48 | 238.43 |
| 14 Fri Aug | 228.65 | 241.82 | 239.88 |
| 13 Thu Aug | 227.12 | 244.02 | 241.06 |
| 12 Wed Aug | 223.95 | 246.04 | 242.53 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 268.59 and 50 EMA is at 260.44
| Date | Closing Price | 50 SMA | 50 EMA |
| 19 Wed Aug | 242.66 | 268.59 | 260.44 |
| 18 Tue Aug | 228.61 | 269.69 | 261.17 |
| 17 Mon Aug | 224.60 | 270.97 | 262.5 |
| 14 Fri Aug | 228.65 | 272.53 | 264.05 |
| 13 Thu Aug | 227.12 | 274.03 | 265.49 |
| 12 Wed Aug | 223.95 | 275.34 | 267.06 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 287.22 and 100 EMA is at 283.97
| Date | Closing Price | 100 SMA | 100 EMA |
| 19 Wed Aug | 242.66 | 287.22 | 283.97 |
| 18 Tue Aug | 228.61 | 287.95 | 284.8 |
| 17 Mon Aug | 224.60 | 288.84 | 285.94 |
| 14 Fri Aug | 228.65 | 289.87 | 287.18 |
| 13 Thu Aug | 227.12 | 290.87 | 288.36 |
| 12 Wed Aug | 223.95 | 291.68 | 289.6 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 331.57 and 200 EMA is at 306.45
| Date | Closing Price | 200 SMA | 200 EMA |
| 19 Wed Aug | 242.66 | 331.57 | 306.45 |
| 18 Tue Aug | 228.61 | 332.64 | 307.09 |
| 17 Mon Aug | 224.60 | 333.77 | 307.88 |
| 14 Fri Aug | 228.65 | 334.9 | 308.72 |
| 13 Thu Aug | 227.12 | 336.16 | 309.53 |
| 12 Wed Aug | 223.95 | 337.41 | 310.36 |
Veru Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Veru Inc, about 28.04% more returns!
Tandem Diabetes has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 47.74% more returns!
Solid Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Solid Biosciences, about 35.1% more returns!
Nektar Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 18.22% more returns!
Marker Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Marker Therapeutics, about 16.45% more returns!
Eyegate Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 10.94% more returns!
Eloxx Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Eloxx Pharmaceuticals, about 62.8% more returns!
Alnylam Pharmaceuticals has performed better than Dare Bioscience in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Biolife Solutions has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 32.36% more returns!
Axogen Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Axogen Inc, about 34.61% more returns!
Atossa Genetics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Atossa Genetics, about 25.49% more returns!
Ascendis Pharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Ascendis Pharma, about 12.98% more returns!
Alnylam Pharmaceuticals has performed better than Ardelyx Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Angiodynamics Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 28.96% more returns!
Amphastar Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 26.84% more returns!
Alkermes Plc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Alkermes Plc, about 5.59% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Alnylam Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 224.5 and Alnylam Pharmaceuticals ALNY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


